Loading...

Amadeo Pesce

TitleAdjunct Professor
InstitutionUniversity of California San Diego
DepartmentPathology
Address9500 Gilman Drive #9113
La Jolla CA 92093
vCardDownload vCard

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Krock K, Pesce A, Ritz D, Thomas R, Cua A, Rogers R, Lipnick P, Kilbourn K. Lower Cutoffs for LC-MS/MS Urine Drug Testing Indicates Better Patient Compliance. Pain Physician. 2017 Nov; 20(7):E1107-E1113. PMID: 29149155.
      View in: PubMed
    2. Metushi IG, Fitzgerald R, Pesce A. Positive Predictive Value of PCP Immunoassay at UC San Diego Health. J Anal Toxicol. 2017 Apr 01; 41(3):258. PMID: 28013286.
      View in: PubMed
    3. Nickley J, Pesce AJ, Krock K. A sensitive assay for urinary cocaine metabolite benzoylecgonine shows more positive results and longer half-lives than those using traditional cut-offs. Drug Test Anal. 2017 Aug; 9(8):1214-1216. PMID: 28024167.
      View in: PubMed
    4. Pesce A, Kirsh KL, Huskey A, Passik SD, Hammett-Stabler CA. A primer on definitive gas and liquid chromatography drug testing: What clinicians need to know. J Opioid Manag. 2015 Jan-Feb; 11(1):27-35. PMID: 25750162.
      View in: PubMed
    5. Darracq MA, Ghafouri N, Pesce A, Cantrell FL. Hand sanitizer intoxication following a crude extraction method. Am J Drug Alcohol Abuse. 2013 May; 39(3):217-8. PMID: 23721538.
      View in: PubMed
    6. West R, Pesce A, West C, Mikel C, Velasco J, Gonzales E, Dizon Z, Almazan P, Latyshev S. Differentiating medicinal from illicit use in positive methamphetamine results in a pain population. J Anal Toxicol. 2013 Mar; 37(2):83-9. PMID: 23316029.
      View in: PubMed
    7. Gonzales E, Ng G, Pesce A, West C, West R, Mikel C, Latyshev S, Almazan P. Stability of pain-related medications, metabolites, and illicit substances in urine. Clin Chim Acta. 2013 Feb 01; 416:80-5. PMID: 23200822.
      View in: PubMed
    8. Crews BO, Pesce AJ, West R, Nguyen H, Fitzgerald RL. Evaluation of high-resolution mass spectrometry for urine toxicology screening in a pain management setting. J Anal Toxicol. 2012 Nov-Dec; 36(9):601-7. PMID: 22995480.
      View in: PubMed
    9. Pesce A, West C, Gonzales E, Rosenthal M, West R, Mikel C, Almazan P, Latyshev S, Horn P. Illicit drug use correlates with negative urine drug test results for prescribed hydrocodone, oxycodone, and morphine. Pain Physician. 2012 Sep-Oct; 15(5):E687-92. PMID: 22996862.
      View in: PubMed
    10. Barakat NH, Atayee RS, Best BM, Pesce AJ. Relationship between the concentration of hydrocodone and its conversion to hydromorphone in chronic pain patients using urinary excretion data. J Anal Toxicol. 2012 May; 36(4):257-64. PMID: 22511700.
      View in: PubMed
    11. Yee DA, Best BM, Atayee RS, Pesce AJ. Observations on the urine metabolic ratio of oxymorphone to oxycodone in pain patients. J Anal Toxicol. 2012 May; 36(4):232-8. PMID: 22511697.
      View in: PubMed
    12. Leimanis E, Best BM, Atayee RS, Pesce AJ. Evaluating the relationship of methadone concentrations and EDDP formation in chronic pain patients. J Anal Toxicol. 2012 May; 36(4):239-49. PMID: 22511698.
      View in: PubMed
    13. Tse SA, Atayee RS, Best BM, Pesce AJ. Evaluating the relationship between carisoprodol concentrations and meprobamate formation and inter-subject and intra-subject variability in urinary excretion data of pain patients. J Anal Toxicol. 2012 May; 36(4):221-31. PMID: 22511696.
      View in: PubMed
    14. Hughes MM, Atayee RS, Best BM, Pesce AJ. Observations on the metabolism of morphine to hydromorphone in pain patients. J Anal Toxicol. 2012 May; 36(4):250-6. PMID: 22511699.
      View in: PubMed
    15. Pesce A, West C, Egan City K, Strickland J. Interpretation of urine drug testing in pain patients. Pain Med. 2012 Jul; 13(7):868-85. PMID: 22494459.
      View in: PubMed
    16. Mikel C, Pesce AJ, Rosenthal M, West C. Therapeutic monitoring of benzodiazepines in the management of pain: current limitations of point of care immunoassays suggest testing by mass spectrometry to assure accuracy and improve patient safety. Clin Chim Acta. 2012 Aug 16; 413(15-16):1199-202. PMID: 22484396.
      View in: PubMed
    17. Fitzgerald RL, Griffin TL, Yun YM, Godfrey RA, West R, Pesce AJ, Herold DA. Dilute and shoot: analysis of drugs of abuse using selected reaction monitoring for quantification and full scan product ion spectra for identification. J Anal Toxicol. 2012 Mar; 36(2):106-11. PMID: 22337779.
      View in: PubMed
    18. Mikel C, Pesce A, West C. 3 things to consider before relying solely on point of care tests for determining benzodiazepine use in chronic pain. Pain Physician. 2012 Mar-Apr; 15(2):E154-5; author reply E155-6. PMID: 22430663.
      View in: PubMed
    19. Pesce A, Crews B, Latyshev S, Mikel C, Almazan P, West R, Rosenthal M, West C. Improvement of pain physicians' practices of opioid management: population-based urinary excretion data. J Opioid Manag. 2011 Nov-Dec; 7(6):435-41. PMID: 22320025.
      View in: PubMed
    20. Reisfield GM, Goldberger BA, Pesce AJ, Crews BO, Wilson GR, Teitelbaum SA, Bertholf RL. Ethyl glucuronide, ethyl sulfate, and ethanol in urine after intensive exposure to high ethanol content mouthwash. J Anal Toxicol. 2011 Jun; 35(5):264-8. PMID: 21619720.
      View in: PubMed
    21. West R, Pesce AJ, Crews B, Mikel C, Rosenthal M, Almazan P, Latyshev S, West C. Determination of illicit drug cutoff values in a pain patient population. Clin Chim Acta. 2011 Aug 17; 412(17-18):1589-93. PMID: 21600890.
      View in: PubMed
    22. Reisfield GM, Goldberger BA, Crews BO, Pesce AJ, Wilson GR, Teitelbaum SA, Bertholf RL. Ethyl glucuronide, ethyl sulfate, and ethanol in urine after sustained exposure to an ethanol-based hand sanitizer. J Anal Toxicol. 2011 Mar; 35(2):85-91. PMID: 21396227.
      View in: PubMed
    23. Pesce A, West C. Drugs-of-abuse testing and therapeutic-drug monitoring. MLO Med Lab Obs. 2011 Mar; 43(3):42, 44, 46. PMID: 21446586.
      View in: PubMed
    24. Pesce A, West C, West R, Crews B, Mikel C, Rosenthal M, Almazon P, Latyshev S. Determination of medication cutoff values in a pain patient population. J Opioid Manag. 2011 Mar-Apr; 7(2):117-22. PMID: 21561035.
      View in: PubMed
    25. Pesce A, West C, Rosenthal M, Mikel C, West R, Crews B, Almazan P, Latyshev S, Horn PS. Illicit drug use in the pain patient population decreases with continued drug testing. Pain Physician. 2011 Mar-Apr; 14(2):189-93. PMID: 21412373.
      View in: PubMed
    26. Crews B, West R, Gutierrez R, Latyshev S, Mikel C, Almazan P, Pesce A, West C, Rosenthal M. An improved method of determining ethanol use in a chronic pain population. J Opioid Manag. 2011 Jan-Feb; 7(1):27-34. PMID: 21434582.
      View in: PubMed
    27. Crews B, Latyshev S, Mikel C, Almazan P, West R, Pesce A, West C. Improved detection of ethyl glucuronide and ethyl sulfate in a pain management population using high-throughput LC-MS/MS. J Opioid Manag. 2010 Nov-Dec; 6(6):415-21. PMID: 21269002.
      View in: PubMed
    28. Norman AB, Norman MK, Tabet MR, Tsibulsky VL, Pesce AJ. Competitive dopamine receptor antagonists increase the equiactive cocaine concentration during self-administration. Synapse. 2011 May; 65(5):404-11. PMID: 20812328; PMCID: PMC3030933.
    29. Pesce A, West C, West R, Crews B, Mikel C, Almazan P, Latyshev S, Rosenthal M, Horn P. Reference intervals: a novel approach to detect drug abuse in a pain patient population. J Opioid Manag. 2010 Sep-Oct; 6(5):341-50. PMID: 21046931.
      View in: PubMed
    30. West R, West C, Crews B, Almazan P, Latyshev S, Rosenthal M, Pesce AJ, Mikel C. Anomalous observations of hydrocodone in patients on oxycodone. Clin Chim Acta. 2011 Jan 14; 412(1-2):29-32. PMID: 20801109.
      View in: PubMed
    31. West R, Pesce A, West C, Crews B, Mikel C, Rosenthal M, Almazan P, Latyshev S. Observations of medication compliance by measurement of urinary drug concentrations in a pain management population. J Opioid Manag. 2010 Jul-Aug; 6(4):253-7. PMID: 20862905.
      View in: PubMed
    32. Pesce A, Rosenthal M, West R, West C, Crews B, Mikel C, Almazan P, Latyshev S. An evaluation of the diagnostic accuracy of liquid chromatography-tandem mass spectrometry versus immunoassay drug testing in pain patients. Pain Physician. 2010 May-Jun; 13(3):273-81. PMID: 20495592.
      View in: PubMed
    33. Pesce A, West C, Rosenthal M, West R, Crews B, Mikel C, Almazan P, Latyshev S, Horn PS. Marijuana correlates with use of other illicit drugs in a pain patient population. Pain Physician. 2010 May-Jun; 13(3):283-7. PMID: 20495593.
      View in: PubMed
    34. Pesce AJ, Tirakis E. Used equipment choices. MLO Med Lab Obs. 2010 Apr; 42(4):68-9. PMID: 20446477.
      View in: PubMed
    35. Mikel C, Pesce A, West C. A tale of two drug testing technologies: GC-MS and LC-MS/MS. Pain Physician. 2010 Jan-Feb; 13(1):91-2. PMID: 20119467.
      View in: PubMed
    36. West R, Pesce A, West C, Crews B, Mikel C, Almazan P, Rosenthal M, Latyshev S. Comparison of clonazepam compliance by measurement of urinary concentration by immunoassay and LC-MS/MS in pain management population. Pain Physician. 2010 Jan-Feb; 13(1):71-8. PMID: 20119465.
      View in: PubMed
    37. Cole JM, Best BM, Pesce AJ. Variability of transdermal fentanyl metabolism and excretion in pain patients. J Opioid Manag. 2010 Jan-Feb; 6(1):29-39. PMID: 20297612.
      View in: PubMed
    38. Crews B, Mikel C, Latyshev S, West R, West C, Pesce A, Friel P. 6-Acetylmorphine detected in the absence of morphine in pain management patients. Ther Drug Monit. 2009 Dec; 31(6):749-52. PMID: 19745789.
      View in: PubMed
    39. Wones R, Pinney SM, Buckholz JM, Deck-Tebbe C, Freyberg R, Pesce A. Medical monitoring: a beneficial remedy for residents living near an environmental hazard site. J Occup Environ Med. 2009 Dec; 51(12):1374-83. PMID: 19952785; PMCID: PMC2868344.
    40. West R, Crews B, Mikel C, Almazan P, Latyshev S, Pesce A, West C. Anomalous observations of codeine in patients on morphine. Ther Drug Monit. 2009 Dec; 31(6):776-8. PMID: 19935365.
      View in: PubMed
    41. Mikel C, Almazan P, West R, Crews B, Latyshev S, Pesce A, West C. LC-MS/MS extends the range of drug analysis in pain patients. Ther Drug Monit. 2009 Dec; 31(6):746-8. PMID: 19935363.
      View in: PubMed
    42. Crews B, Mikel C, Latyshev S, West R, Pesce A. Unstable propoxyphene metabolite excreted in human urine is detected by liquid chromatography-tandem mass spectrometry. J Anal Toxicol. 2009 Sep; 33(7):379-83. PMID: 19796508.
      View in: PubMed
    43. Norman AB, Tabet MR, Norman MK, Buesing WR, Pesce AJ, Ball WJ. A chimeric human/murine anticocaine monoclonal antibody inhibits the distribution of cocaine to the brain in mice. J Pharmacol Exp Ther. 2007 Jan; 320(1):145-53. PMID: 17023573.
      View in: PubMed
    44. Mazzella FM, Smith D, Horn P, Cotelingam JD, Rector JT, Shrit MA, Pesce A, Schumacher HR. Prognostic significance of pronormoblasts in erythrocyte predominant myelodysplastic patients. Am J Hematol. 2006 Jul; 81(7):484-91. PMID: 16755568.
      View in: PubMed
    45. Miles MV, Horn PS, Tang PH, Morrison JA, Miles L, DeGrauw T, Pesce AJ. Age-related changes in plasma coenzyme Q10 concentrations and redox state in apparently healthy children and adults. Clin Chim Acta. 2004 Sep; 347(1-2):139-44. PMID: 15313151.
      View in: PubMed
    46. Miles MV, Morrison JA, Horn PS, Tang PH, Pesce AJ. Coenzyme Q10 changes are associated with metabolic syndrome. Clin Chim Acta. 2004 Jun; 344(1-2):173-9. PMID: 15149886.
      View in: PubMed
    47. Horn PS, Pesce AJ. Reference intervals: an update. Clin Chim Acta. 2003 Aug; 334(1-2):5-23. PMID: 12867273.
      View in: PubMed
    48. Miles MV, Horn PS, Morrison JA, Tang PH, DeGrauw T, Pesce AJ. Plasma coenzyme Q10 reference intervals, but not redox status, are affected by gender and race in self-reported healthy adults. Clin Chim Acta. 2003 Jun; 332(1-2):123-32. PMID: 12763289.
      View in: PubMed
    49. Horn PS, Pesce AJ. Effect of ethnicity on reference intervals. Clin Chem. 2002 Oct; 48(10):1802-4. PMID: 12324505.
      View in: PubMed
    50. Tang PH, Miles MV, Steele P, DeGrauw A, Chuck G, Schroer L, Pesce A. Anticoagulant effects on plasma coenzyme Q(10) estimated by HPLC with coulometric detection. Clin Chim Acta. 2002 Apr; 318(1-2):127-31. PMID: 11880122.
      View in: PubMed
    51. Hammett-Stabler CA, Pesce AJ, Cannon DJ. Urine drug screening in the medical setting. Clin Chim Acta. 2002 Jan; 315(1-2):125-35. PMID: 11728415.
      View in: PubMed
    Amadeo's Networks
    Concepts
    Derived automatically from this person's publications.
    _
    Co-Authors
    People in Profiles who have published with this person.
    _
    Related Authors
    People who share related concepts with this person.
    _